COMORBIDITY AND ADVERSE EVENTS IN ACQUIRED HEMOPHILIA A: DATA FROM THE GTH-AHA-EMI STUDY





Prediction of immunotherapy responsiveness in melanoma through single-cell sequencing-based characterization of the tumor immune microenvironment

Immune checkpoint inhibitors (ICB) therapy have emerged as effective treatments for melanomas.However, the response of melanoma patients to ICB has been highly heterogenous.Here, by analyzing integrated scRNA-seq datasets from melanoma patients, we revealed significant differences in the TiME composition between ICB-resistant and responsive tissues

read more